Jump to content

Left ventricular hypertrophy

From Wikipedia, the free encyclopedia
(Redirected fromLVH)
Left ventricular hypertrophy
A heart with left ventricular hypertrophy in short-axis view
SpecialtyCardiology
ComplicationsHypertrophic cardiomyopathy,Heart failure[1]
Diagnostic methodEchocardiography,cardiovascular MRI[1]
Differential diagnosisAthletic heart syndrome

Left ventricular hypertrophy(LVH) isthickeningof theheart muscleof the leftventricleof theheart,that is, left-sidedventricular hypertrophyand resulting increasedleft ventricular mass.

Causes

[edit]

While ventricular hypertrophyoccurs naturallyas a reaction toaerobic exerciseandstrength training,it is most frequently referred to as a pathological reaction tocardiovascular disease,orhigh blood pressure.[2]It is one aspect ofventricular remodeling.

While LVH itself is not a disease, it is usually a marker for disease involving the heart.[3]Disease processes that can cause LVH include any disease that increases theafterloadthat the heart has to contract against, and some primary diseases of themuscle of the heart.[citation needed] Causes of increased afterload that can cause LVH includeaortic stenosis,aortic insufficiencyandhypertension.Primary disease of the muscle of the heart that cause LVH are known ashypertrophic cardiomyopathies,which can lead into heart failure.[citation needed]

Long-standingmitral insufficiencyalso leads to LVH as a compensatory mechanism.[citation needed]

LV mass increases withageing.[4]

Associated genes includeOGN,osteoglycin.[5]

Diagnosis

[edit]

The commonly used method to diagnose LVH isechocardiography,with which the thickness of the muscle of the heart can be measured. Theelectrocardiogram(ECG) often shows signs of increased voltage from the heart in individuals with LVH, so this is often used as a screening test to determine who should undergo further testing.[citation needed]

Echocardiography

[edit]
Left ventricular hypertrophy grading
by posterior wall thickness[6]
Mild 12 to 13 mm
Moderate >13 to 17 mm
Severe >17 mm

Two dimensional echocardiography can produce images of the left ventricle. The thickness of the left ventricle as visualized on echocardiography correlates with its actual mass. Left ventricular mass can be further estimated based on geometric assumptions of ventricular shape using the measured wall thickness and internal diameter.[7]Average thickness of the left ventricle, with numbers given as 95%prediction intervalfor the short axis images at the mid-cavity level are:[8]

  • Women: 4 – 8 mm
  • Men: 5 – 9 mm

CT & MRI

[edit]

CTandMRI-based measurement can be used to measure the left ventricle in three dimensions and calculate left ventricular mass directly. MRI based measurement is considered the “gold standard”for left ventricular mass,[9]though is usually not readily available for common practice. In older individuals, age related remodeling of the left ventricle's geometry can lead to a discordancy between CT and echocardiographic based measurements of left ventricular mass.[4]

ECG criteria

[edit]
Left ventricular hypertrophy with secondary repolarization abnormalities as seen on ECG
Histopathologyof (a) normal myocardium and (b) myocardial hypertrophy. Scale bar indicates 50 μm.
Gross pathologyof left ventricular hypertrophy. Left ventricle is at right in image, serially sectioned from apex to near base.

There are several sets of criteria used to diagnose LVH via electrocardiography.[10]None of them are perfect, though by using multiple criteria sets, thesensitivityandspecificityare increased.

TheSokolow-Lyon index:[11][12]

  • S in V1+ R in V5or V6(whichever is larger) ≥ 35 mm (≥ 7 large squares)
  • R in aVL ≥ 11 mm

TheCornell voltage criteria[13]for the ECG diagnosis of LVH involve measurement of the sum of the R wave in lead aVL and the S wave in lead V3.The Cornell criteria for LVH are:

  • S in V3+ R in aVL > 28 mm (men)
  • S in V3+ R in aVL > 20 mm (women)

TheRomhilt-Estes point score system( "diagnostic" >5 points; "probable" 4 points):

ECG Criteria Points
Voltage Criteria (any of):
  1. R or S in limb leads ≥20 mm
  2. S in V1or V2≥30 mm
  3. R in V5or V6≥30 mm
3
ST-T Abnormalities:
  • ST-T vector opposite to QRS without digitalis
  • ST-T vector opposite to QRS with digitalis

3
1

Negative terminal P mode in V11 mm in depth and 0.04 sec in duration (indicatesleft atrial enlargement) 3
Left axis deviation (QRS of −30° or more) 2
QRS duration ≥0.09 sec 1
Delayedintrinsicoid deflectionin V5or V6(>0.05 sec) 1

Other voltage-based criteria for LVH include:

  • Lead I: R wave > 14 mm
  • Lead aVR: S wave > 15 mm
  • Lead aVL: R wave > 12 mm
  • Lead aVF: R wave > 21 mm
  • Lead V5:R wave > 26 mm
  • Lead V6:R wave > 20 mm

Diagnostic accuracy of electrocardiography in left ventricular hypertrophy can be enhanced withartificial intelligenceanalysis.[14]

Treatment

[edit]

Treatment is typically focused on resolving the cause of the LVH with the enlargement not permanent in all cases. In some cases the growth can regress with the reduction of blood pressure.[15]

LVH may be a factor in determining treatment or diagnosis for other conditions, for example, LVH is used in the staging and risk stratification of Non-ischemic cardiomyopathies such as Fabry's Disease.[16]Patients with LVH may have to participate in more complicated and precise diagnostic procedures, such as Echocardiography or Cardiac MRI.[17][18]

See also

[edit]

References

[edit]
  1. ^abMaron BJ, Maron MS (January 2013). "Hypertrophic cardiomyopathy".Lancet.381(9862). Elsevier BV: 242–255.doi:10.1016/s0140-6736(12)60397-3.PMID22874472.S2CID38333896.
  2. ^"Ask the doctor: Left Ventricular Hypertrophy".Retrieved2007-12-07.
  3. ^Meijs MF, Bots ML, Vonken EJ, Cramer MJ, Melman PG, Velthuis BK, et al. (2007)."Rationale and design of the SMART Heart study: A prediction model for left ventricular hypertrophy in hypertension".Netherlands Heart Journal.15(9): 295–298.doi:10.1007/BF03086003.PMC1995099.PMID18030317.
  4. ^abStokar J, Leibowitz D, Durst R, Shaham D, Zwas DR (2019-10-24)."Echocardiography overestimates LV mass in the elderly as compared to cardiac CT".PLOS ONE.14(10): e0224104.Bibcode:2019PLoSO..1424104S.doi:10.1371/journal.pone.0224104.PMC6812823.PMID31648248.
  5. ^Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, et al. (May 2008)."Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass".Nature Genetics.40(5): 546–552.doi:10.1038/ng.134.PMC2742198.PMID18443592.
  6. ^Goland S, Czer LS, Kass RM, Siegel RJ, Mirocha J, De Robertis MA, et al. (March 2008). "Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool".Journal of the American College of Cardiology.51(12): 1214–1220.doi:10.1016/j.jacc.2007.11.052.PMID18355661.S2CID29478910.
  7. ^Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. (January 2015)."Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging".Journal of the American Society of Echocardiography.28(1): 1–39.e14.doi:10.1016/j.echo.2014.10.003.hdl:1854/LU-5953422.PMID25559473.
  8. ^Kawel N, Turkbey EB, Carr JJ, Eng J, Gomes AS, Hundley WG, et al. (July 2012)."Normal left ventricular myocardial thickness for middle-aged and older subjects with steady-state free precession cardiac magnetic resonance: the multi-ethnic study of atherosclerosis".Circulation. Cardiovascular Imaging.5(4): 500–508.doi:10.1161/CIRCIMAGING.112.973560.PMC3412148.PMID22705587.
  9. ^Myerson SG, Bellenger NG, Pennell DJ (March 2002)."Assessment of left ventricular mass by cardiovascular magnetic resonance".Hypertension.39(3): 750–755.doi:10.1161/hy0302.104674.PMID11897757.S2CID16598370.
  10. ^"Lesson VIII - Ventricular Hypertrophy".Retrieved2009-01-07.
  11. ^Sokolow M, Lyon TP (February 1949). "The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads".American Heart Journal.37(2): 161–186.doi:10.1016/0002-8703(49)90562-1.PMID18107386.
  12. ^Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfield P (April 1998). "Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy".Hypertension.31(4): 937–942.CiteSeerX10.1.1.503.8356.doi:10.1161/01.HYP.31.4.937.PMID9535418.S2CID2662286.
  13. ^Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P (March 1987). "Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings".Circulation.75(3): 565–572.doi:10.1161/01.CIR.75.3.565.PMID2949887.S2CID25815927.
  14. ^Martínez-Sellés, Manuel; Marina-Breysse, Manuel (2023)."Current and Future Use of Artificial Intelligence in Electrocardiography".Journal of Cardiovascular Development and Disease.10(4): 175.doi:10.3390/jcdd10040175.PMC10145690.PMID37103054.
  15. ^Gradman AH, Alfayoumi F (2006). "From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease".Progress in Cardiovascular Diseases.48(5): 326–341.doi:10.1016/j.pcad.2006.02.001.PMID16627048.
  16. ^Tower-Rader A, Jaber WA (November 2019)."Multimodality Imaging Assessment of Fabry Disease".Circulation. Cardiovascular Imaging.12(11): e009013.doi:10.1161/CIRCIMAGING.119.009013.PMID31718277.
  17. ^American Society of Nuclear Cardiology,"Five Things Physicians and Patients Should Question"(PDF),Choosing Wisely: an initiative of theABIM Foundation,American Society of Nuclear Cardiology, archived fromthe original(PDF)on April 16, 2012,retrievedAugust 17,2012
  18. ^Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. (August 2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine".Journal of the American College of Cardiology.50(7): e1–e157.doi:10.1161/CIRCULATIONAHA.107.185752.PMID17692738.
[edit]